Literature DB >> 30879065

Expanded circulating peripheral helper T cells in systemic lupus erythematosus: association with disease activity and B cell differentiation.

Ayako Makiyama1,2, Asako Chiba1, Daisuke Noto1, Goh Murayama1,2, Ken Yamaji2, Naoto Tamura2, Sachiko Miyake1.   

Abstract

OBJECTIVE: Peripheral helper T (TPH) cells are a recently identified Th cell subset that promotes B cell differentiation and antibody production in inflamed tissues. This study investigated circulating TPH cells to determine their involvement in systemic lupus erythematosus (SLE).
METHODS: Peripheral blood mononuclear cells collected from SLE patients and healthy individuals were analysed. TPH cells were identified as CD3+CD4+CD45RA-CXCR5- cells with a high expression of PD-1. The frequency, activation status and subsets of TPH cells were evaluated by flow cytometry. The production of IL-21 was assessed by intracellular staining and the association of TPH cells with disease activity and B cell populations was determined.
RESULTS: Circulating TPH cells, identified as CD3+CD4+CD45RA-PD-1highCXCR5- cells were increased in the peripheral blood of SLE patients compared with controls. Circulating TPH cells produced similar amounts of IL-21 compared with follicular Th cells. The expansion and activation of TPH cells were correlated with SLE disease activity. Activated TPH cells, particularly Th1-type TPH cells, were associated with the promotion of B cell differentiation in SLE patients.
CONCLUSION: The association of TPH cells with disease activity suggests the involvement of extrafollicular T-B cell interactions in the pathogenesis of SLE. TPH cells promote autoantibody production in aberrant lymphoid organs and therefore might be a novel therapeutic target in autoantibody-producing disorders.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  B cell differentiation; disease activity; peripheral helper T cells; systemic lupus erythematosus

Mesh:

Substances:

Year:  2019        PMID: 30879065     DOI: 10.1093/rheumatology/kez077

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  17 in total

1.  Systemic lupus erythematosus - a disease of two halves?

Authors:  Mark N Lazarus
Journal:  Rheumatology (Oxford)       Date:  2019-10-01       Impact factor: 7.580

2.  Tph Cells Expanded in Primary Sjögren's Syndrome.

Authors:  Weiqian Chen; Fan Yang; Jin Lin
Journal:  Front Med (Lausanne)       Date:  2022-06-09

3.  Different antibody-associated autoimmune diseases have distinct patterns of T follicular cell dysregulation.

Authors:  Filipa Ribeiro; Vasco C Romão; Sara Rosa; Kátia Jesus; Ana Água-Doce; Sofia C Barreira; Patrícia Martins; Susana Lopes da Silva; Ema Nobre; Maria João Bugalho; Válter R Fonseca; João Eurico Fonseca; Luis Graca
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

Review 4.  T peripheral helper cells in autoimmune diseases.

Authors:  Kathryne E Marks; Deepak A Rao
Journal:  Immunol Rev       Date:  2022-02-01       Impact factor: 12.988

5.  Impaired B cell anergy is not sufficient to breach tolerance to nuclear antigen in Vκ8/3H9 lupus-prone mice.

Authors:  Kieran P Manion; Yuriy Baglaenko; Nan-Hua Chang; Nafiseh Talaei; Joan E Wither
Journal:  PLoS One       Date:  2020-07-28       Impact factor: 3.240

Review 6.  IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus.

Authors:  Xuewei Ding; Wei Xiang; Xiaojie He
Journal:  Front Immunol       Date:  2020-11-11       Impact factor: 7.561

7.  Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sjögren syndrome.

Authors:  Anastasia Dupré; Juliette Pascaud; Elodie Rivière; Audrey Paoletti; Bineta Ly; Michael Mingueneau; Xavier Mariette; Gaetane Nocturne
Journal:  RMD Open       Date:  2021-03

8.  Effects of Tocilizumab Therapy on Circulating B Cells and T Helper Cells in Patients With Neuromyelitis Optica Spectrum Disorder.

Authors:  Ye Liu; Huiming Zhang; Tian-Xiang Zhang; Meng Yuan; Chen Du; Pei Zeng; Zhenning Huang; Dongmei Jia; Guili Yang; Fu-Dong Shi; Chao Zhang
Journal:  Front Immunol       Date:  2021-07-29       Impact factor: 7.561

9.  Dysregulated B cell differentiation towards antibody-secreting cells in neuromyelitis optica spectrum disorder.

Authors:  Yasunobu Hoshino; Daisuke Noto; Shuhei Sano; Yuji Tomizawa; Kazumasa Yokoyama; Nobutaka Hattori; Sachiko Miyake
Journal:  J Neuroinflammation       Date:  2022-01-06       Impact factor: 8.322

10.  Bronchoalveolar Lavage Fluid Reflects a TH1-CD21low B-Cell Interaction in CVID-Related Interstitial Lung Disease.

Authors:  David Friedmann; Susanne Unger; Baerbel Keller; Mirzokhid Rakhmanov; Sigune Goldacker; Gernot Zissel; Björn C Frye; Jonas C Schupp; Antje Prasse; Klaus Warnatz
Journal:  Front Immunol       Date:  2021-02-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.